Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Window-of-Opportunity Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

NCT07826949 is registered in ClinicalTrials.gov with Nicholas Butowski as lead sponsor.

NCT NCT07826949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Window-of-Opportunity Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.
Lead sponsor
Nicholas Butowski
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
December 31, 2031
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain neoplasm, glioma, recurrent high-grade gliomas